Skip to main content


  • Poster presentation
  • Open Access

Switching from systemic steroids to high doses of ciclesonide restores the hypothalamic pituitary-adrenal axis

  • 1,
  • 2 and
  • 2
Clinical and Translational Allergy20133 (Suppl 1) :P27

  • Published:


  • Asthma
  • Cortisol
  • Pulmonary Function Test
  • Asthma Control
  • Hypothalamic Pituitary Adrenal Axis


Treatment of difficult asthma with oral corticosteroids (OCS) may suppress hypothalamic-pituitary-adrenal axis. In this study we checked if high doses of ciclesonide instead of OCS may restore the adrenal function without loss of the disease control.


In five asthmatics with poor control of the disease despite treatment with systemic corticosteroids OC were replaced with high doses of ciclesonide (1600-2400 µg/day). The pulmonary function tests (PFTs), asthma control test and the morning levels of cortisol and ACTH were measured at baseline and in 28 and 56 day of treatment.


All patients improved in asthma control scores from mean value 9,4 to, 19,8 in 70 days. In four subjects FEV1 improved significantly with mean increase of up to 585 ml in 70 days ACTH levels were normalized in 3 patients after 28 days of observation and in all patients after 56 days. Cortisol level was normalized in 3 patients after 28 days and in next two subjects after 56 days.


In patients with difficult to treat asthma switching from the prednisone to high doses of ciclesonide may normalize hypothalamic pituitary adrenal axis function and improves the disease control and PFTs.

Authors’ Affiliations

Medical University of Lodz, Poland
Department of Pneumonology and Allergy, Medical University of Lodz, Poland


© Marczak et al; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.